16 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Assertio Therapeutics, Inc. ASRT stock increased by 57.7% to $1.64 during Friday's pre-market session.

• Seelos Therapeutics, Inc. SEEL stock moved upwards by 12.2% to $1.01. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $2.00.

• Catalyst Biosciences, Inc. CBIO stock rose 10.4% to $8.30.

• Pacific Biosciences, Inc. PACB stock moved upwards by 8.9% to $5.25.

Losers

• Salarius Pharmaceuticals, Inc. SLRX stock declined 39.7% to $1.20 during Friday's pre-market session.

• Zogenix, Inc. ZGNX stock plummeted 31.3% to $36.15.

• Myriad Genetics, Inc. MYGN shares declined 29.2% to $20.75.

• Miragen Therapeutics, Inc. MGEN shares declined 19.5% to $1.03. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.

• Tonix Pharmaceuticals, Inc. TNXP stock fell 17.3% to $0.72.

• Aurora Cannabis, Inc. ACB shares fell 15.2% to $1.70. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.

• ADMA Biologics, Inc. ADMA shares decreased by 9.0% to $3.64.

• RAPT Therapeutics, Inc. RAPT shares decreased by 9.0% to $30.60. The most recent rating by UBS, on December 04, is at Buy, with a price target of $31.00.

• Applied Genetic Tech, Inc. AGTC shares decreased by 8.1% to $5.25. The most recent rating by Roth Capital, on January 28, is at Buy, with a price target of $25.00.

• Guardion Health Sciences, Inc. GHSI stock plummeted 7.8% to $0.28.

• Corbus Pharmaceuticals, Inc. CRBP stock declined 5.2% to $6.50.

• Canopy Growth, Inc. CGC stock plummeted 3.3% to $20.48. According to the most recent rating by BMO Capital, on January 28, the current rating is at Outperform.